All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Pituitary and hypothalamic hormones and analogues

Signifor

(pasireotide)

Uses, side effects, dosage information & price range

Recordati Rare Diseases

About this medicine

Signifor is indicated for the treatment of adult patients with Cushing’s disease for whom surgery is not an option or for whom surgery has failed. Signifor is indicated for the treatment of adult patients with acromegaly for whom surgery is not an option or has not been curative and who are inadequately controlled on treatment with another somatostatin analogue.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

RyeqoComposition: relugolix;estradiol;norethisterone acetateGedeon Richter Plc.
Price on RequestView Details →
PalsonifyComposition: paltusotineCrinetics Pharmaceuticals Europe GmbH
Price on RequestView Details →
IncrelexComposition: mecaserminEsteve Pharmaceuticals, S.A.
Price on RequestView Details →
CetrotideComposition: cetrorelixMerck Europe B.V.
Price on RequestView Details →
OrgalutranComposition: ganirelixOrganon N.V.
Price on RequestView Details →

Key Information

Salt / Composition

pasireotide

Category

Pituitary and hypothalamic hormones and analogues

Manufacturer

Recordati Rare Diseases

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.